Janssen Pharma to present VIPS data at major conference

Customer data presentation at the Bioprocessing Summit in Boston

NEWS - Bournemouth, UK – 30th July, 2018: Solentim, the innovator and leader in Cell Line Development instrumentation, is pleased to announce that Janssen Pharmaceutical (part of Johnson & Johnson) will be presenting data from the VIPS single cell seeding platform at the forthcoming CHI 10th Annual Bioprocessing Summit in Boston.

The talk will be given on Friday 17th August by Thomas Kelly from Janssen R&D in Spring House, PA and is entitled “High Throughput Cell Development using the VIPS”  and is part of the Optimizing Cell Line Development conference stream.

The presentation will include Janssen’s data for seeding efficiency improvements, outgrowth and reduced 'ghost' wells. It will also discuss how the VIPS has dramatically benefited their overall cell line development workflow.

Find out more about the 10th Annual Bioprocessing Summit and reserve your place by visiting the conference website at http://www.bioprocessingsummit.com/Cell-Line-Development/